{
    "xml": "<topic id=\"PHP1803\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/theophylline\" basename=\"theophylline\" title=\"THEOPHYLLINE\">\n<title>THEOPHYLLINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_734\" namespace=\"/interactions/list-of-drug-interactions/theophylline\">Theophylline</xref>\n</p>\n<data name=\"vtmid\">66493003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_474269260\" title=\"Xanthines\">Xanthines</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP47749\" outputclass=\"indicationsAndDose\" rev=\"1.17\" parent=\"/drugs/theophylline\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>Dose adjustment may be necessary if smoking started or stopped during treatment.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"pharmacokinetics\">\n<title>Pharmacokinetics</title>\n<p>Theophylline is metabolised in the liver. The plasma-theophylline concentration is increased in heart failure, hepatic impairment, and in viral infections. The plasma-theophylline concentration is decreased in smokers, and by alcohol consumption. Differences in the half-life of theophylline are important because the toxic dose is close to the therapeutic dose.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47825\" outputclass=\"cautions\" rev=\"1.18\" parent=\"/drugs/theophylline\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Cardiac arrhythmias or other cardiac disease</ph>; <ph outputclass=\"caution\">elderly (increased plasma-theophylline concentration)</ph>; <ph outputclass=\"caution\">epilepsy</ph>; <ph outputclass=\"caution\">fever</ph>; <ph outputclass=\"caution\">hypertension</ph>; <ph outputclass=\"caution\">hyperthyroidism</ph>; <ph outputclass=\"caution\">peptic ulcer</ph>; <ph outputclass=\"caution\">risk of hypokalaemia</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47742\" outputclass=\"interactions\" rev=\"1.11\" parent=\"/drugs/theophylline\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (theophylline).</p>\n<p>The plasma-theophylline concentration is increased by drugs that inhibit its metabolism.</p>\n<p>The plasma-theophylline concentration is decreased by drugs that induce its metabolism.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47631\" outputclass=\"sideEffects\" rev=\"1.20\" parent=\"/drugs/theophylline\">\n<title>Side-effects</title>\n<body>\r\n<section outputclass=\"generalSideEffects\">\r\n<sectiondiv outputclass=\"frequencies\">\r\n\r\n\r\n\r\n\r\n<sectiondiv outputclass=\"notKnown\">\r\n<p outputclass=\"title\">Frequency not known</p>\r\n<p outputclass=\"sideEffects\">\r\n<ph outputclass=\"sideEffect\">Arrhythmias</ph>; <ph outputclass=\"sideEffect\">CNS stimulation</ph>; <ph outputclass=\"sideEffect\">convulsions</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">gastric irritation</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">insomnia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">palpitation</ph>; <ph outputclass=\"sideEffect\">tachycardia</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\r\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n<section outputclass=\"sideEffectsAdvice\">\r\n<title>Side-effects, further information</title>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Hypokalaemia</p>\r\n<p>Potentially serious hypokalaemia may result from beta<sub>2</sub> agonist therapy. Particular caution is required in severe asthma, because this effect may be potentiated by concomitant treatment with theophylline and its derivatives, corticosteroids, and diuretics, and by hypoxia. Plasma-potassium concentration should therefore be monitored in severe asthma.</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"sideEffectsOverdosageInformation\">\r\n<title>Overdose</title>\r\n<sectiondiv>\r\n<p>Theophylline in overdose can cause vomiting (which may be severe and intractable), agitation, restlessness, dilated pupils, sinus tachycardia, and hyperglycaemia. More serious effects are haematemesis, convulsions, and supraventricular and ventricular arrhythmias. Severe hypokalaemia may develop rapidly.</p>\r\n<p>For details on the management of poisoning, see Theophylline, under <xref format=\"dita\" href=\"#PHP78558\" type=\"bookmark\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\">Emergency treatment of poisoning</xref>.</p>\n</sectiondiv>\n</section>\r\n</body>\n</topic>\n<topic id=\"PHP47725\" outputclass=\"pregnancy\" parent=\"/drugs/theophylline\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Neonatal irritability and apnoea have been reported.</p>\n<p>Theophylline can be taken as normal during pregnancy as it is particularly important that asthma should be well controlled during pregnancy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47829\" outputclass=\"breastFeeding\" parent=\"/drugs/theophylline\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Present in milk&#8212;irritability in infant reported; modified-release preparations preferable.</p>\n<p>Theophylline can be taken as normal during breast-feeding.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47764\" outputclass=\"hepaticImpairment\" parent=\"/drugs/theophylline\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Reduce dose.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47581\" outputclass=\"monitoringRequirements\" parent=\"/drugs/theophylline\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"therapeuticDrugMonitoring\">\n<sectiondiv>\n<p>In most individuals, a plasma-theophylline concentration of 10&#8211;20&#8239;mg/litre (55&#8211;110&#8239;micromol/litre) is required for satisfactory bronchodilation, although a lower plasma-theophylline concentration of 5&#8211;15&#8239;mg/litre may be effective. Adverse effects can occur within the range 10&#8211;20&#8239;mg/litre and both the frequency and severity increase at concentrations above 20&#8239;mg/litre. </p>\n<p>Plasma-theophylline concentration is measured 5 days after starting oral treatment and at least 3 days after any dose adjustment. A blood sample should usually be taken 4&#8211;6 hours after an oral dose of a modified-release preparation (sampling times may vary&#8212;consult local guidelines).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57392\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.12\" parent=\"/drugs/theophylline\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Modified release</p>\n<p>The rate of absorption from modified-release preparations can vary between brands. If a prescription for a modified-release oral theophylline preparation does not specify a brand name, the pharmacist should contact the prescriber and agree the brand to be dispensed. Additionally, it is essential that a patient discharged from hospital should be maintained on the brand on which that patient was stabilised as an in-patient.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1803-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/theophylline\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: suppository, oral suspension, oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76268\" title=\"Modified-release tablet\" namespace=\"/drugs/theophylline/modified-release-tablet\">Modified-release tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76260\" title=\"Modified-release capsule\" namespace=\"/drugs/theophylline/modified-release-capsule\">Modified-release capsule</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78360\" namespace=\"/treatment-summaries/asthma\" title=\"Asthma\" count=\"6\" rel=\"backlink\">Asthma</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78465\" namespace=\"/treatment-summaries/bronchodilators\" title=\"Bronchodilators\" count=\"5\" rel=\"backlink\">Bronchodilators</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78467\" namespace=\"/treatment-summaries/respiratory-system\" title=\"Respiratory system\" count=\"1\" rel=\"backlink\">Respiratory system</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78538\" namespace=\"/treatment-summaries/chronic-obstructive-pulmonary-disease\" title=\"Chronic obstructive pulmonary disease\" count=\"1\" rel=\"backlink\">Chronic obstructive pulmonary disease</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78560\" namespace=\"/treatment-summaries/substance-dependence\" title=\"Substance dependence\" count=\"1\" rel=\"backlink\">Substance dependence</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_734\" namespace=\"/interactions/list-of-drug-interactions/theophylline\" title=\"Theophylline\" count=\"1\" rel=\"link\">Theophylline</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78558\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\" title=\"Emergency treatment of poisoning\" count=\"1\" rel=\"link\">Emergency treatment of poisoning</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76268\" namespace=\"/drugs/theophylline/modified-release-tablet\" title=\"Modified-release tablet\" count=\"1\" rel=\"link\">Modified-release tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76260\" namespace=\"/drugs/theophylline/modified-release-capsule\" title=\"Modified-release capsule\" count=\"1\" rel=\"link\">Modified-release capsule</xref>\n</links>\n</topic>",
    "id": "PHP1803",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/theophylline",
    "basename": "theophylline",
    "title": "THEOPHYLLINE",
    "interactants": [
        {
            "id": "bnf_int_734",
            "label": "Theophylline"
        }
    ],
    "vtmid": "66493003",
    "drugClassification": [
        "Xanthines"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "Dose adjustment may be necessary if smoking started or stopped during treatment.",
                "html": "<p>Dose adjustment may be necessary if smoking started or stopped during treatment.</p>"
            }
        ],
        "pharmacokinetics": [
            {
                "type": "pharmacokinetics",
                "title": "Pharmacokinetics",
                "textContent": "Theophylline is metabolised in the liver. The plasma-theophylline concentration is increased in heart failure, hepatic impairment, and in viral infections. The plasma-theophylline concentration is decreased in smokers, and by alcohol consumption. Differences in the half-life of theophylline are important because the toxic dose is close to the therapeutic dose.",
                "html": "<p>Theophylline is metabolised in the liver. The plasma-theophylline concentration is increased in heart failure, hepatic impairment, and in viral infections. The plasma-theophylline concentration is decreased in smokers, and by alcohol consumption. Differences in the half-life of theophylline are important because the toxic dose is close to the therapeutic dose.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Cardiac arrhythmias or other cardiac disease",
                "html": "Cardiac arrhythmias or other cardiac disease"
            },
            {
                "type": "cautions",
                "textContent": "elderly (increased plasma-theophylline concentration)",
                "html": "elderly (increased plasma-theophylline concentration)"
            },
            {
                "type": "cautions",
                "textContent": "epilepsy",
                "html": "epilepsy"
            },
            {
                "type": "cautions",
                "textContent": "fever",
                "html": "fever"
            },
            {
                "type": "cautions",
                "textContent": "hypertension",
                "html": "hypertension"
            },
            {
                "type": "cautions",
                "textContent": "hyperthyroidism",
                "html": "hyperthyroidism"
            },
            {
                "type": "cautions",
                "textContent": "peptic ulcer",
                "html": "peptic ulcer"
            },
            {
                "type": "cautions",
                "textContent": "risk of hypokalaemia",
                "html": "risk of hypokalaemia"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (theophylline).\n\nThe plasma-theophylline concentration is increased by drugs that inhibit its metabolism.\n\nThe plasma-theophylline concentration is decreased by drugs that induce its metabolism.",
                "html": "<p>Appendix 1 (theophylline).</p><p>The plasma-theophylline concentration is increased by drugs that inhibit its metabolism.</p><p>The plasma-theophylline concentration is decreased by drugs that induce its metabolism.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Arrhythmias",
                        "html": "Arrhythmias",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "CNS stimulation",
                        "html": "CNS stimulation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "convulsions",
                        "html": "convulsions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastric irritation",
                        "html": "gastric irritation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "insomnia",
                        "html": "insomnia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "palpitation",
                        "html": "palpitation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tachycardia",
                        "html": "tachycardia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Hypokalaemia",
                "textContent": "Potentially serious hypokalaemia may result from beta2 agonist therapy. Particular caution is required in severe asthma, because this effect may be potentiated by concomitant treatment with theophylline and its derivatives, corticosteroids, and diuretics, and by hypoxia. Plasma-potassium concentration should therefore be monitored in severe asthma.",
                "html": "<p>Potentially serious hypokalaemia may result from beta<sub>2</sub> agonist therapy. Particular caution is required in severe asthma, because this effect may be potentiated by concomitant treatment with theophylline and its derivatives, corticosteroids, and diuretics, and by hypoxia. Plasma-potassium concentration should therefore be monitored in severe asthma.</p>"
            }
        ],
        "overdosageInformation": [
            {
                "type": "overdosageInformation",
                "references": [
                    {
                        "id": "PHP78558",
                        "label": "Emergency treatment of poisoning"
                    }
                ],
                "textContent": "Theophylline in overdose can cause vomiting (which may be severe and intractable), agitation, restlessness, dilated pupils, sinus tachycardia, and hyperglycaemia. More serious effects are haematemesis, convulsions, and supraventricular and ventricular arrhythmias. Severe hypokalaemia may develop rapidly.\n\nFor details on the management of poisoning, see Theophylline, under Emergency treatment of poisoning.",
                "html": "<p>Theophylline in overdose can cause vomiting (which may be severe and intractable), agitation, restlessness, dilated pupils, sinus tachycardia, and hyperglycaemia. More serious effects are haematemesis, convulsions, and supraventricular and ventricular arrhythmias. Severe hypokalaemia may develop rapidly.</p><p>For details on the management of poisoning, see Theophylline, under <xref format=\"dita\" href=\"#PHP78558\" type=\"bookmark\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\">Emergency treatment of poisoning</xref>.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Neonatal irritability and apnoea have been reported.\n\nTheophylline can be taken as normal during pregnancy as it is particularly important that asthma should be well controlled during pregnancy.",
                "html": "<p>Neonatal irritability and apnoea have been reported.</p><p>Theophylline can be taken as normal during pregnancy as it is particularly important that asthma should be well controlled during pregnancy.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Present in milk&#8212;irritability in infant reported; modified-release preparations preferable.\n\nTheophylline can be taken as normal during breast-feeding.",
                "html": "<p>Present in milk&#8212;irritability in infant reported; modified-release preparations preferable.</p><p>Theophylline can be taken as normal during breast-feeding.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Reduce dose.",
                "html": "<p>Reduce dose.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "therapeuticDrugMonitoring": [
            {
                "type": "therapeuticDrugMonitoring",
                "textContent": "In most individuals, a plasma-theophylline concentration of 10&#8211;20 mg/litre (55&#8211;110 micromol/litre) is required for satisfactory bronchodilation, although a lower plasma-theophylline concentration of 5&#8211;15 mg/litre may be effective. Adverse effects can occur within the range 10&#8211;20 mg/litre and both the frequency and severity increase at concentrations above 20 mg/litre.\n\nPlasma-theophylline concentration is measured 5 days after starting oral treatment and at least 3 days after any dose adjustment. A blood sample should usually be taken 4&#8211;6 hours after an oral dose of a modified-release preparation (sampling times may vary&#8212;consult local guidelines).",
                "html": "<p>In most individuals, a plasma-theophylline concentration of 10&#8211;20&#8239;mg/litre (55&#8211;110&#8239;micromol/litre) is required for satisfactory bronchodilation, although a lower plasma-theophylline concentration of 5&#8211;15&#8239;mg/litre may be effective. Adverse effects can occur within the range 10&#8211;20&#8239;mg/litre and both the frequency and severity increase at concentrations above 20&#8239;mg/litre. </p><p>Plasma-theophylline concentration is measured 5 days after starting oral treatment and at least 3 days after any dose adjustment. A blood sample should usually be taken 4&#8211;6 hours after an oral dose of a modified-release preparation (sampling times may vary&#8212;consult local guidelines).</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "title": "Modified release",
                "textContent": "The rate of absorption from modified-release preparations can vary between brands. If a prescription for a modified-release oral theophylline preparation does not specify a brand name, the pharmacist should contact the prescriber and agree the brand to be dispensed. Additionally, it is essential that a patient discharged from hospital should be maintained on the brand on which that patient was stabilised as an in-patient.",
                "html": "<p>The rate of absorption from modified-release preparations can vary between brands. If a prescription for a modified-release oral theophylline preparation does not specify a brand name, the pharmacist should contact the prescriber and agree the brand to be dispensed. Additionally, it is essential that a patient discharged from hospital should be maintained on the brand on which that patient was stabilised as an in-patient.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "suppository",
                "oral suspension",
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76268",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76260",
                "label": "Modified-release capsule",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78360",
                "label": "Asthma",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78465",
                "label": "Bronchodilators",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78467",
                "label": "Respiratory system",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78538",
                "label": "Chronic obstructive pulmonary disease",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78560",
                "label": "Substance dependence",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_734",
                "label": "Theophylline",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78558",
                "label": "Emergency treatment of poisoning",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76268",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76260",
                "label": "Modified-release capsule",
                "type": "medicinalForm"
            }
        ]
    }
}